Načítá se...

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency

Alpha-1-antitrypsin deficiency (AATD), also known as alpha1-proteinase inhibitor deficiency, is an autosomal co-dominant condition. The genotypes associated with AATD include null, deficient, and dysfunctional alpha-1-antitrypsin (A1AT) variants, which result in low levels of circulating functional...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Petrache, Irina, Hajjar, Joud, Campos, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2009
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2726081/
https://ncbi.nlm.nih.gov/pubmed/19707408
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!